Sun Protection and Tanning Awareness in Rural Schools
Launched by UNIVERSITY OF UTAH · Nov 15, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at ways to help high school students in rural areas understand the risks of skin cancer, specifically melanoma, and how to protect themselves from it. The program will include educational sessions in classrooms, where students will learn about sun safety and the dangers of tanning. The goal is to not only educate the students but also to make sure this important information continues to be available to them even after the study is finished. After the program is implemented, researchers will conduct interviews and surveys to see how effective the education has been.
To participate in this trial, students need to be enrolled in a Utah high school, specifically in grades 9 through 12. There are no specific exclusions, meaning if you're a student in those grades, you can join. Participants can expect interactive learning sessions and the chance to provide feedback on what they learned. This trial is important because it aims to empower young people with knowledge that can help them make safer choices regarding sun exposure and skin health.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Students are eligible if they are enrolled in a Utah high school (e.g. grades 9-12).
- Exclusion Criteria:
- • None
About University Of Utah
The University of Utah is a prestigious research institution known for its commitment to advancing medical knowledge and improving patient care through innovative clinical trials. With a robust infrastructure that supports a wide range of biomedical research initiatives, the university leverages its multidisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical studies. By fostering collaboration among researchers, clinicians, and community partners, the University of Utah aims to translate scientific discoveries into effective therapies and interventions, ultimately enhancing health outcomes and contributing to the advancement of medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Salt Lake City, Utah, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported